Lazard Asset Management LLC Recursion Pharmaceuticals, Inc. Transaction History
Lazard Asset Management LLC
- $63.4 Billion
- Q2 2025
A detailed history of Lazard Asset Management LLC transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 404,364 shares of RXRX stock, worth $2.02 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
404,364
Previous 506,138
20.11%
Holding current value
$2.02 Million
Previous $2.68 Million
23.57%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding RXRX
# of Institutions
371Shares Held
290MCall Options Held
7.75MPut Options Held
6.1M-
Vanguard Group Inc Valley Forge, PA36.1MShares$180 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl33MShares$165 Million1.38% of portfolio
-
Baillie Gifford & CO24MShares$120 Million0.09% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$86.6 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$73.3 Million0.31% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $902M
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...